0001209191-20-038890.txt : 20200625
0001209191-20-038890.hdr.sgml : 20200625
20200625161500
ACCESSION NUMBER: 0001209191-20-038890
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200623
FILED AS OF DATE: 20200625
DATE AS OF CHANGE: 20200625
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lippoldt Darin
CENTRAL INDEX KEY: 0001504783
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22705
FILM NUMBER: 20989411
MAIL ADDRESS:
STREET 1: C/O VOLCANO CORPORATION
STREET 2: 3661 VALLEY CENTRE DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEUROCRINE BIOSCIENCES INC
CENTRAL INDEX KEY: 0000914475
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330525145
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12780 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 617-7600
MAIL ADDRESS:
STREET 1: 12780 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-23
0
0000914475
NEUROCRINE BIOSCIENCES INC
NBIX
0001504783
Lippoldt Darin
12780 EL CAMINO REAL
SAN DIEGO
CA
92130
0
1
0
0
Chief Legal Officer
Common Stock
2020-06-23
4
M
0
5000
32.99
A
31021
D
Common Stock
2020-06-23
4
S
0
5000
130.00
D
26021
D
Incentive Stock Option
32.99
2020-06-23
4
M
0
5000
32.99
D
2025-02-03
Common Stock
5000
0
D
The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.
Option granted February 3, 2015 and vested monthly over four years.
/s/ Darin Lippoldt
2020-06-25